Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01973205 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 900
- Enrollment target
NCT01973205: Completed Phase 3 study, sponsored by Novartis.
NCT01973205 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 900 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (17% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01973205, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 900 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy and safety of acetaminophen and aspirin versus placebo in the acute treatment of migraine
Primary Outcome
Number of subjects who are pain free at the 2-hour assessment
Interventions
- DRUG Placebo
- DRUG Acetaminophen 250 mg and Aspirin 250 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
What the finished NCT01973205 record still lists
NCT01973205 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (17% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01973205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01973205 about?
NCT01973205 is a clinical study titled "Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine". The purpose of the study is to evaluate the efficacy and safety of acetaminophen and aspirin versus placebo in the acute treatment of migraine
What is the current status of trial NCT01973205?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 900 participants. The study started on 2013-10. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01973205?
The interventions under investigation include: Placebo (DRUG), Acetaminophen 250 mg and Aspirin 250 mg (DRUG).
Who is sponsoring clinical trial NCT01973205?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01973205's enrollment target sits among peer trials
900 350th of 2000 higher than 1,641 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia